TY - JOUR
T1 - Personalized Medicine’s Coming of Age
T2 - One Drug, One Patient
AU - Qazilbash, Muzaffar H.
AU - Kwak, Larry W.
N1 - Publisher Copyright:
©2023 American Association for Cancer Research.
PY - 2023
Y1 - 2023
N2 - A dendritic cell/myeloma fusion vaccine, given with lenalidomide and GM-CSF, did not result in a statistically significant increase in CR rates at 1 year posttransplant but was associated with a significant increase in circulating multiple myeloma–reactive lymphocytes indicative of tumor-specific immunity. See related article by Chung et al., p.
AB - A dendritic cell/myeloma fusion vaccine, given with lenalidomide and GM-CSF, did not result in a statistically significant increase in CR rates at 1 year posttransplant but was associated with a significant increase in circulating multiple myeloma–reactive lymphocytes indicative of tumor-specific immunity. See related article by Chung et al., p.
UR - http://www.scopus.com/inward/record.url?scp=85178648954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178648954&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-23-2194
DO - 10.1158/1078-0432.CCR-23-2194
M3 - Article
C2 - 37733765
AN - SCOPUS:85178648954
SN - 1078-0432
VL - 29
SP - 4703
EP - 4705
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 23
ER -